Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Consolidated Net Income (2022 - 2025)

Historic Consolidated Net Income for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to -$7.7 million.

  • CervoMed's Consolidated Net Income fell 6263.68% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.6 million, marking a year-over-year decrease of 11415.39%. This contributed to the annual value of -$16.3 million for FY2024, which is 11452.27% down from last year.
  • According to the latest figures from Q3 2025, CervoMed's Consolidated Net Income is -$7.7 million, which was down 6263.68% from -$6.2 million recorded in Q2 2025.
  • CervoMed's 5-year Consolidated Net Income high stood at -$1.2 million for Q2 2023, and its period low was -$7.7 million during Q3 2025.
  • For the 4-year period, CervoMed's Consolidated Net Income averaged around -$3.8 million, with its median value being -$2.8 million (2022).
  • As far as peak fluctuations go, CervoMed's Consolidated Net Income skyrocketed by 4205.55% in 2023, and later tumbled by 18404.8% in 2024.
  • Quarter analysis of 4 years shows CervoMed's Consolidated Net Income stood at -$4.1 million in 2022, then surged by 42.06% to -$2.4 million in 2023, then tumbled by 184.05% to -$6.7 million in 2024, then decreased by 15.16% to -$7.7 million in 2025.
  • Its last three reported values are -$7.7 million in Q3 2025, -$6.2 million for Q2 2025, and -$4.9 million during Q1 2025.